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Abstracts
Background: Resistance rate of Escherichia coli against antimicrobials that are commonly prescribed in pediatric
urinary tract infections is currently a matter of concern.
Methods: The antimicrobial susceptibility patterns of uropathogenic Escherichia coli strains to the common
antibimcrobials ampicillin, cotrimoxazole, coamoxyclav, ceftazidime, ceftriaxone, nitrofurantoin, and gentamycin
were determined in 177 children aged from 2 to 36 months. They presented with their first symptomatic
community acquired urinary tract infection at the Department of Pediatrics, San Leopoldo Mandic Hospital, Merate-
Lecco.
Results: High rates of ampicillin (inpatients: 50%; outpatients: 52%) resistance were identified. The resistance for
cotrimoxazole (inpatients: 22%; outpatients: 15%) and especially coamoxyclav (inpatients: 6%; outpatients: 10%) was
less pronounced than that to ampicillin. No resistance or less than 1% of resistance was identified for ceftazidime,
ceftriaxone, nitrofurantoin, and gentamycin both in inpatients and in outpatients.
Conclusions: Italian children affected with a community acquired urinary tract infection are initially managed orally
with coamoxyclav or parenterally with ceftriaxone. The results of the present retrospective analysis support this
attitude. Parenteral ceftriaxone or an aminoglycoside should be considered for patients on antimicrobial
prophylaxis or recently prescribed antimicrobials.
Background
Urinary tract infections are common bacterial infections
of childhood [1,2]. Prompt recognition and correct anti-
microbial management relieve symptoms and prevent
kidney damage [1,2]. Since drug management is usually
started before the responsible microorganism and its
susceptibility to antimicrobial agents are known, the
choice relies on local epidemiologic data. Considering
that Escherichia coli accounts for 60 to 80% of commu-
nity acquired urinary tract infections, initial empiric
therapy includes antimicrobial agents that provide cov-
erage for that particular bacterium [1,2].
The results of a study performed between 2000 and
2005 in North East Italy indicate that both oral
coamoxyclav and parenteral ceftriaxone are very effective
in the management of childhood pyelonephritis [3].
Resistance to commonly prescribed antimicrobials
agents, caused among others by the production of
extended spectrum beta lactamases, is currently a matter
of increasing concern [4]. We studied the susceptibility
to antimicrobials of Escherichia coli strains that cause
symptomatic community-acquired urinary tract infec-
tions in small children treated at our institution.
Materials and methods
T h es t u d yi sar e t r o s p e c t i v ea n a l y s i so fb a c t e r i ai s o l a t e d
from urinary tract cultures performed during the 3-year
period from 2007 to 2009 at the Department of Pedia-
trics, San Leopoldo Mandic Hospital, Merate (Lecco), a
Northern Italy hospital.
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36 months presenting with their first symptomatic com-
munity acquired urinary tract infection. Infants less than
6 months of age, toxic or ill appearing children, and
patients unable to retain oral fluids were admitted for
parenteral antimicrobial management. Uncertainty about
outpatient adherence to the recommended regimen of
care was a further indication for admission. Children
with known urinary tract malformations or antimicrobial
prophylaxis were excluded. In the patients urine,
collected either by clean catch method or by bladder
catheterization, contained 25 or more white cells per
μicroliter, and the culture grew only one micro-organism
and ≥ 100,000 colony forming units per milliliter (mid-
stream collection) respectively ≥ 10,000 colony forming
units per milliliter (transurethral catheterization).
Standard techniques were used for culture and identi-
fication of pathogens [5]. Escherichia coli susceptibility
testing was performed using the disk diffusion technique
according to the guidelines of the Clinical and Labora-
tory Standards Institute. Inhibition halo diameter was
interpreted for each isolate to determine susceptibility,
which was defined as susceptible, intermediate, or resis-
tant [5]. Following common antimicrobials were tested:
ampicillin, coamoxyclav, cotrimoxazole, ceftazidime, cef-
triaxone, nitrofurantoin, and gentamycin.
For analysis the two-tailed Fisher exact test was used [6].
Statistical significance was defined as a P value of < 0.05.
Results
During the study period, a total of 275 consecutive chil-
dren, 145 (53%) girls and 130 (47%) boys between 2 and
36 months of age, were included. Urine had been
obtained by clean catch method in 243 and by bladder
catheterization in the remaining 32 children. Germs
other than Escherichia coli caused the infection in 98
(36%) cases: Proteus mirabilis (N = 40; 15%), Pseudomo-
nas aeruginosa (N = 19; 7%), Enterococcus species (N =
17; 6%), Klebsiella pneumoniae (N = 12; 4%), other uro-
pathogens (N = 10; 4%).
Escherichia coli was isolated in the remaining 177
(64%) children. This germ was isolated in 153 of the 243
(63%) collections performed by clean catch method and
in 24 of the 32 (75%) collections performed by bladder
catheterization (difference not significant).
The antimicrobial susceptibility of isolated Escherichia
coli strains appears in figure 1. Considering that uro-
pathogenic Escherichia coli strains with intermediate
susceptibility are considered clinically sensitive, high
rates of ampicillin (inpatients: 34 cases, 50%; outpatients:
57 cases, 52%) resistance were identified. The resistance
for cotrimoxazole (inpatients: 15 cases, 22%; outpatients:
16 cases, 15%) and especially coamoxyclav (inpatients:
4 cases, 6%; outpatients: 11 cases; 10%) was less
pronounced than that to ampicillin. No resistance or
less than 1% of resistance was identified for ceftazidime,
ceftriaxone, nitrofurantoin, and gentamycin both in
inpatients and in outpatients. The resistance rate was
not statistically different in inpatients as compared with
outpatients.
Age distribution ranged between 2 and 12 months in
107 (60%) and between 13 and 36 months in the
remaining 70 subjects (40%), as given in table 1. While
the majority of children aged between 2 and 12 months
were admitted, the majority of those aged between 13
and 36 months were not admitted (P < 0.001). Further-
more, while the majority of the children aged between 2
and 13 months were boys, the majority of those aged
between 13 and 36 months were girls (P < 0.001). The
antimicrobial susceptibility of isolated Escherichia coli
strains was similar in both age groups.
Discussion
The results of the present analysis performed in small
children with their first Escherichia coli community
acquired urinary tract infection confirm that these infec-
tions are more prevalent among males during the first
year of life and among females thereafter [1,2]. Further-
more our data confirm that the resistance rate of
Escherichia coli against cotrimoxazole and especially
ampicillin, antimicrobials that are commonly prescribed
in these children, is currently a matter of concern. On
the contrary, resistance against coamoxyclav was
uncommon. Finally, no significant resistance was noted
against nitrofurantoin, third-generation cephalosporins
like ceftazidime or ceftriaxone, and the established ami-
noglycoside gentamycin.
Antimicrobial resistance has reached crisis stage in
human medicine [4]. The crucial factor underlying resis-
tance is antimicrobial use within both human and veter-
inary medicine (the greater the duration of exposure,
the greater the risk of the development of resistance
irrespective of the severity of the need for antimicro-
bials). In the present analysis children on antimicrobial
prophylaxis and patients with hospital acquired infec-
tions were not included: in these patients testing for
resistance is biased towards higher rates of resistance
[4]. However, we did not specifically address the possi-
ble prescription of antimicrobials in the weeks preceding
the urinary tract infection, a further possible cause of
reduced antimicrobial susceptibility [1,2].
In this study Escherichia coli was isolated more fre-
quently in urine obtained by clean catch method than in
urine obtained by bladder catheterization. This observa-
tion might suggest some degree of contamination in
samples obtained without catheterization.
High resistance rates of Escherichia coli against ampi-
cillin and cotrimoxazole have also been recently noted
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and Austria, indicating that management with these
agents may be inadequate in many cases [7-9].
Susceptibility to nitrofurantoin has remained practi-
cally unchanged since its introduction into clinical prac-
tice more than 50 years ago [10]. Since standard
medication with nitrofurantoin does not achieve thera-
peutic concentrations in the bloodstream, its use is
advised only for uncomplicated cystitis [10]. Fluoroqui-
nolones are widely prescribed to treat urinary tract
infections in adulthood [11]. We did not address the
susceptibility pattern of these drugs to Escherichia coli
Figure 1 Susceptibility to ampicillin, cotrimoxazole, coamoxyclav, ceftazidime, ceftriaxone, nitrofurantoin, and gentamycin in 177
pediatric urinary tract infections caused by Escherichia coli. The affected children were treated either as inpatients (N = 68; 38%) or as
outpatients (N = 109; 62%). Inpatients are given full colors, outpatient patterned colors. No difference was noted between inpatients and
outpatients.
Table 1 Influence of age on resistance to ampicillin, cotrimoxazole, and coamoxyclav in 177 pediatric urinary tract
infections caused by Escherichia coli
2-12 Months of Age 13-36 Months of Age Significance
N 107 70
Gender, male: female 57: 50 19: 51 P < 0.001
Inpatients/outpatients 50/57 18/52 P < 0.001
Escherichia coli Resistance, N (%)
Ampicillin significant 56 (52%) 35 (50%) Not
Coamoxyclav significant 6 (6%) 9 (13%) Not
Cotrimoxazole significant 16 (15%) 15 (21%) Not
No resistance or less than 1% of resistance was identified for ceftazidime, ceftriaxone, nitrofurantoin, and gentamycin.
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there may be an increased risk of fluoroquinolone-asso-
ciated cartilage lesions [11].
Coamoxyclav is currently widely used and recom-
mended [12] in Italy for the empirical oral management
of children affected with a community acquired urinary
tract infection. The rate of in vitro resistance to this
antimicrobial noted in the present study performed
between 2007 and 2009 is almost identical to that noted
in North East in Italy between 2000 and 2005 [3]. Con-
sidering that coamoxyclav is concentrated in the urine
and susceptibility testing is mostly based upon blood
concentration determinations, this antimicrobial might
o f t e nb ee f f e c t i v ef o rt h et r e a t m e n to fu r i n a r yt r a c t
infections even when in vitro susceptibility testing sug-
gests full resistance. On the other side, the very good
susceptibility pattern of isolated Escherichia coli to
third-generation cephalosporins and aminoglycosides
support the current role of these drugs in the treatment
of childhood urinary tract infection.
In this study, the susceptibility to antimicrobials was
identical and age-independent in inpatients and outpati-
ents with a community acquired urinary tract infection,
as previously noted in the literature [1,2]. These obser-
vations suggest, that in uropathogens bacterial virulence
that causes severe disease and, subsequently, increases
the risk factor for hospitalization, is not related to sus-
ceptibility to antimicrobials.
Conclusions
The results of the present analysis support the recom-
mendations of the Italian Society of Pediatric Nephrol-
ogy to initially manage children affected with a
community acquired urinary tract infection with either
oral coamoxyclav or parenteral ceftriaxone. Parenteral
ceftriaxone or an aminoglycoside should be considered
for patients on antimicrobial prophylaxis or recently
prescribed antimicrobials.
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